Categories: aggregated

New THC-CBD Pill for MS and Huntington’s Disease May Be First to Benefit from Biden’s New Marijuana Research Bill

In related news, President Biden signed the Marijuana Research and Expansion Act into law. This will speed up researchers’ bids for DEA schedule 1 registration authorization to undertake these trials. After seven hard years of waiting, the MMJ group of firms can finish their mission of performing clinical studies on Huntington’s Disease and Multiple Sclerosis. MMJ has received FDA Orphan Designation for its Huntington’s disease clinical trials.

Jason

Share
Published by
Jason

Recent Posts

Slapwoods Honors DJ Screw With Its First Official Collaboration

Slapwoods is announcing its first-ever official collaboration with DJ Screw, the late Houston legend whose…

9 hours ago

Resistance Is Fertile: A Conversation With Logan Grendel of Focused on Infinity

It could be so easy to believe that cannabis culture is something that has been…

9 hours ago

Pink Boost Goddess in Mendocino: Discover Emerald Spirit Botanicals magical family farm

Modern cultivation techniques and spiritual practices collide with Pink Boost Goddess on our next Legendary…

9 hours ago

Housing Crisis, Fentanyl, and Dogs With ODs: The Hidden Toll of Skid Row’s Opioid Epidemic

Animal rescuers and advocacy groups say dogs living on Skid Row are suffering from neglect,…

1 day ago

Cannabis Doesn’t Distort Reality. It Shows You the Director’s Cut.

This article originally appeared in High Times’ 50th Anniversary print issue. It is an excerpt…

2 days ago

Regulated, Untamed, and Built to Last: Inside Montana Cannabis

How Montana built a legal cannabis market from a thin medical marijuana law, federal raids,…

3 days ago